Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Facio-Scapulo-Humeral Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Site 2, Liverpool, New South Wales, Australia

  • Research Site 3, Auchenflower, Queensland, Australia

  • Research Site 1, Birtinya, Queensland, Australia

  • Research Site 4, Melbourne, Victoria, Australia

  • Research Site 2, Calgary, Alberta, Canada

  • Research Site 3, Edmonton, Alberta, Canada

  • Research Site 1, Montreal, Quebec, Canada

  • Research Site 2, München, Germany

  • Research Site 1, Ulm, Germany

  • Research Site 1, Milan, Italy

  • Research Site 2, Roma, Italy

  • Research Site 1, Leiden, Netherlands

  • Research Site 1, Auckland, New Zealand

  • Research Site 3, Barcelona, Spain

  • Research Site 2, Madrid, Spain

  • Research Site 1, Valencia, Spain

  • Research Site, Bangkok, Thailand